Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE:M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

Since February 2021, Macy’s stock’s one-year return has outperformed several of the world’s most popular vaccine stocks: Moderna Inc (NASDAQ:MRNA), Pfizer Inc. (NYSE:PFE), BioNTech SE - ADR (NASDAQ:BNTX), Novavax, Inc. (NASDAQ:NVAX) and Vaxart Inc (NASDAQ:VXRT).

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.